Mechanisms of lysophosphatidic acid-induced DNA synthesis in vascular smooth muscle cells

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 3, 2003, Pages 381-387

  Xu, Yan Jun ^b   Rathi, Satyajeet S ^b   Chapman, Donald C ^b   Arneja, Amarjit S ^b   Dhalla, Naranjan S ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b NONE

Author keywords

Casein kinase II Cell proliferation; Lysophosphatidic acid; Mitogen activated protein kinase; Phosphatidylinositol 3 kinase; Vascular smooth muscle cell

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CASEIN KINASE II; CYCLOSPORIN A; DAIDZEIN; DILTIAZEM; DNA; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; THYMIDINE; VERAPAMIL;

ANIMAL CELL; AORTA; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DNA SYNTHESIS; DOSE TIME EFFECT RELATION; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CALCIUM; CASEIN KINASE II; CELLS, CULTURED; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; LYSOPHOSPHOLIPIDS; MUSCLE, SMOOTH, VASCULAR; PROTEIN-SERINE-THREONINE KINASES; RATS;

EID: 0242371801     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200303000-00006     Document Type: Article

References (32)

1. Eichholtz N,Jalink K, Fahrefort I, et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J. 1993;291:677-89.
2. Toker A, Cantley L. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 1997;1387:67-6.
3. Tokumura A, Iimori M, Nishioka Y, et al. Lysophosphatidic acid induces proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol. 1994;267:C204-10.
4. Brindley DN, Waggoner DW. Phosphatidate phosphohydrolase and signal transduction. Chem Physics Lipid. 1996;80:45-7.
5. Nyrop M, Zweifler AJ. Platelet aggregation in hypertension and the effects of antihypertensive treatment. J Hypertens. 1998;6:263-9.
6. Tomoda F, Takata M, Kagitani S, et al. Different platelet aggregability during mental stress in two stages of essential hypertension. Am J Hypertens. 1999;12:1063-70.
7. Xu Y-J, Rathi SS, Zhang M, et al. Mechanism of the positive inotropic effect of lysophosphatidic acid in rat heart. J Cardiovasc Pharmacol Ther. 2002;7:109-15.
8. Seewald S, Sachinidis A, Dusing R, et al. Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells. Atherosclerosis. 1997;130:121-31.
9. Seewald S, Schmitz U, Seul C, et al. Lysophosphatidic acid stimulates protein kinase C isoforms alpha, beta, epsilon, and zeta in pertussis toxin sensitive pathway in vascular smooth muscle cells. Am J Hypertens. 1999;12:532-7.
10. Xu YJ, Kim SO, Liao DF, et al. Stimulation of 90- and 70-kDa ribosomal protein S6 kinases by arginine vasopressin and lysophosphatidic acid in rat cardiomyocytes. Biochem Pharmacol. 2000;59:1163-71.
11. Litchfiel D, Luscher B. Casein kinase II in signal transduction and cell cycle regulation. Mol Cell Biochem. 1993;127/128:187-99.
12. Pepperkok R, Lorenz P, Jakobi R, et al. Cell growth stimulation by EGF: inhibition through antisense-oligodeoxynucleotides demonstrates important role of casein kinase II. Exp Cell Res. 1991;197:245-53.
13. Sharma SK, Zahradka P, Chapman D, et al. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. J Pharmacol Exp Ther. 1999;290:1475-81.
14. Xu YJ, Yau L, Yu LP, et al. Stimulation of protein synthesis by phosphatidic acid in rat cardiomyocytes. Biochem Pharmacol. 1996;52:1735-40.
15. 2+ and cardiac contractile force. Am J Physiol. 1996;271:H651-9.
16. Filhol O, Cochet C, Chambaz M. Cytoplasmic and nuclear distribution of casein kinase II: characterization of the enzyme uptake by bovine adrenocortical nuclear preparation. Biochemistry. 1990;29:9928-36.
17. Tomono M, Toyoshima K, Ito M, et al. Calcineurin is essential for DNA synthesis in Swiss 3T3 fibroblasts. Biochem J. 1996;317:675-80.
18. Dixon RJ, Brunskill NJ. Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: role of PI 3-kinase and ERK. Kidney Int. 1999;56:2064-75.
19. Yamakawa T, Tanaka S, Numaguchi, et al. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension. 2000;35:313-8.
20. Wang Y, Huang S, Sah VP, et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem. 1998;23:2161-8.
21. Reiser CO, Lanz T, Hofmann F, et al. Lysophosphatidic acid-mediated signal-transduction pathway is involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins. Biochem J. 1998;330:1107-14.
22. Ito T, Kozawa O, Tanabe K, et al. p38 MAP kinase is required for vasopressin-stimulated HSP27 induction in aortic smooth muscle cells. Hypertension. 2000;35:673-8.
23. Sayed M, Kim SO, Salh BS, et al. Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase. J Biol Chem. 2000;275:16569-73.
24. Fleckenstein-Grun G. Calcium antagonism in vascular smooth muscle cells. Pflugers Arch. 1996;432:R53-60.
25. Kataoka S, Alam R, Dash PK, et al. Inhibition of PDGF-mediated proliferation of vascular smooth muscle cells by calcium antagonists. Stroke. 1997;28:364-9.
26. Carpio LC, Dziax R. Phosphatidic acid effects on cytosolic calcium and proliferation in osteoblastic cells. Prostaglanding Leukot Essent Fatty Acids. 1998;59:101-9.
27. ++ of human adult vascular smooth muscle cells in culture. Thromb Res. 1999;94:317-26.
28. Tomono M, Toyoshima K, Ito M, et al. Inhibition of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. Arch Biochem Biophys. 1998;353:374-8.
29. Medina J, Wolf A. Strategies to antagonise the cyclosporine A-induced proliferation of human pulmonary artery smooth muscle cells: anti-endothelin-1 antibodies, verapamil, and octreotide. Biochem Pharmacol. 2000;59:1459-66.
30. An S. Molecular identification and characterization of G protein-coupled receptors for lysophophatidic acid and sphingosine 1-phosphate. Ann N Y Acad Sci. 2000;905:25 -33.
31. 2+ control lysophosphatidate signaling through EDG-2 receptors. J Biol Chem. 2000;275:27520-30.
32. Fukushima N, Ishii I, Contos JJA, et al. Lysophospholipid receptors. Annu Rev Pharmacol Toxicol. 2001;41:507-34.